Core A: Administrative Core

核心A:行政核心

基本信息

  • 批准号:
    10652549
  • 负责人:
  • 金额:
    $ 39.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-15 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

Since its inception in 1996, the Boston University (BU) Alzheimer Disease (AD) Research Center (ADRC) has had a singular mission to facilitate leading-edge research on Alzheimer's disease (AD) and AD related dementias (ADRD). The function of the Administrative Core (AC) is to ensure that administrative processes are in place to support this mission. The Core manages and coordinates internal interactions between the ADRC director and core leaders, interactions between the BU ADRC and investigators at BU and elsewhere, BU administration, staff at NIA, and local and national community organizations. The AC integrates, coordinates, directs and plans all BU ADRC activities and ensures compliance with all human subjects, scientific integrity, and financial policy requirements of NIH. This includes providing an effective structure to support our scientific efforts focused on studying AD/ADRD disease heterogeneity, ensuring the availability of our diverse cohorts, and supporting and implementing the themes and goals of the National Alzheimer's Plan Project Act (NAPA). The progress of the ADRC as a whole and its individual core component will be monitored to ensure accountability to NAPA and NIA milestones and goals. The AC fosters innovative AD/ADRD research by providing visionary leadership and by facilitating cross-core interactions and coordinating the provision of resources to support qualified investigators at BU and other local, national, and international research programs. The AC facilitates partnerships with the local, regional, national and international AD/ADRD research community to support high-impact AD/ADRD research. The AC will ensure that all mandated data sets are submitted to NACC in an accurate and timely manner and that biological specimens are submitted to the NCRAD. The AC ensures that we support and inform the communities we serve regarding the benefits of the BU ADRC and AD/ADRD research and to solicit feedback and advice from them. The AC is under the leadership of BU ADRC Director Dr. Neil Kowall who reports directly to the Dean of BU School of Medicine. In his role as BU ADRC Director he is supported by an Executive Committee comprised of BU ADRC core leaders and other senior thought leaders at BU. Other administrative committees include an External Advisory Committee, Internal Advisory Committee, and Community Action Council. In collaboration with the BU ADRC Director, these committees are responsible for coordinating, planning, overseeing, and evaluating all BU ADRC activities and ensuring the optimal utilization of BU ADRC resources. The AC administers the developmental project program to support meritorious projects focused on basic or clinical AD/ADRD research. A Developmental Project Review Panel will be commissioned review, select, and monitor these projects. Ongoing, interactive communication and input will be solicited from multiple sources, including our institutional research community, external AD/ADRD experts, and NIA, to strengthen and improve our Center's performance.
自1996年成立以来,波士顿大学(BU)阿尔茨海默氏病(AD)研究中心(ADRC)已有 有一个单一的使命,以促进有关阿尔茨海默氏病(AD)和与AD相关的领先研究 痴呆症(ADRD)。管理核心(AC)的功能是确保行政流程是 支持这项任务。核心管理并协调ADRC之间的内部互动 BU和其他地方的BU ADRC与研究人员之间的互动董事和核心领导者,BU 行政管理,NIA的员工以及地方和国家社区组织。 AC集成,坐标, 指导和计划所有BU ADRC活动,并确保遵守所有人类主题,科学完整性, 和NIH的财务政策要求。这包括提供有效的结构来支持我们的科学 旨在研究AD/ADRD疾病异质性的努力,以确保我们的各种队列的可用性, 并支持和实施《国家阿尔茨海默氏症计划法案》(NAPA)的主题和目标。 将监控ADRC的整体及其各个核心组件的进度,以确保 对纳帕和NIA里程碑和目标的问责制。 AC促进了创新的广告/ADRD研究 提供有远见的领导力并通过促进交叉互动并协调提供 支持BU和其他本地,国家和国际研究的合格调查员的资源 程序。 AC促进与本地,地区,国家和国际广告/ADRD的合作伙伴关系 研究社区支持高影响力广告/ADRD研究。 AC将确保所有授权数据 集合以准确,及时的方式提交给NACC,并将生物标本提交给NACC Ncrad。 AC确保我们支持并告知我们服务的社区有关 BU ADRC和AD/ADRD研究,并征求他们的反馈和建议。 AC在 BU ADRC主任尼尔·科沃尔(Neil Kowall)博士的领导,直接向BU医学院院长报告。在 他担任BU ADRC主任的角色,他得到了由BU ADRC Core组成的执行委员会的支持 BU的领导人和其他高级思想领袖。其他行政委员会包括外部咨询 委员会,内部咨询委员会和社区行动委员会。与BU ADRC合作 这些委员会主任负责协调,计划,监督和评估所有BU ADRC 活动并确保BU ADRC资源的最佳利用。 AC管理发育 支持基本或临床广告/ADRD研究的项目计划。一个 发展项目审查小组将进行委托审查,选择和监视这些项目。 持续的,互动的沟通和投入将从多种来源征集,包括我们的机构 研究社区,外部广告/ADRD专家和NIA,以加强和改善我们的中心的 表现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Neil W. Kowall其他文献

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
多组学分析探索阿尔茨海默病神经影像倡议队列中的血液代谢生物标志物
  • DOI:
    10.1038/s41598-024-56837-1
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Takaki Oka;Yuki Matsuzawa;Momoka Tsuneyoshi;Yoshitaka Nakamura;Ken Aoshima;H. Tsugawa;Michael Paul Ronald Clifford R. William John Q. Arthur W. Weiner Aisen Petersen Jack Jagust Trojanowki Toga ;Michael Weiner;P. Aisen;Ron Petersen;Clifford R Jack;William Jagust;J. Trojanowki;Arthur W Toga;L. Beckett;Robert C. Green;Andrew J. Saykin;John C. Morris;Leslie M. Shaw;Enchi Liu;T. Montine;R. G. Thomas;Michael Donohue;Sarah Walter;D. Gessert;T. Sather;G. Jiminez;Danielle Harvey;M. Bernstein;Nick Fox;Paul Thompson;N. Schuff;Charlie S. DeCarli;B. Borowski;J. Gunter;Matthew Senjem;P. Vemuri;David Jones;K. Kantarci;C. Ward;Robert A. Koeppe;Norman L. Foster;Eric M Reiman;Kewei Chen;C. Mathis;Susan Landau;Nigel J. Cairns;E. Householder;Lisa Taylor Reinwald;V. Lee;M. Korecka;M. Figurski;K. Crawford;S. Neu;Tatiana M Foroud;S. Potkin;L. Shen;Faber Kelley;Sungeun Kim;K. Nho;Zaven Kachaturian;Richard Frank;Peter J. Snyder;S. Molchan;J. Kaye;Joseph Quinn;B. Lind;R. Carter;S. Dolen;Lon S. Schneider;S. Pawluczyk;Mauricio Beccera;L. Teodoro;B. Spann;J. Brewer;H. Vanderswag;A. Fleisher;J. Heidebrink;J. Lord;S. Mason;C. Albers;D. Knopman;K. Johnson;Rachelle S. Doody;Javier Villanueva Meyer;M. Chowdhury;S. Rountree;M. Dang;Y. Stern;Lawrence S. Honig;Karen L. Bell;B. Ances;John C. Morris;M. Carroll;Sue Leon;E. Householder;M. Mintun;S. Schneider;A. Oliver;D. Marson;R. Griffith;D. Clark;David S Geldmacher;J. Brockington;Erik Roberson;H. Grossman;Effie M. Mitsis;L. de Toledo‐Morrell;R. Shah;R. Duara;D. Varon;Maria T. Greig;Peggy Roberts;Marilyn S. Albert;C. Onyike;D. D’Agostino;S. Kielb;James E. Galvin;D. Pogorelec;Brittany Cerbone;Christina A. Michel;H. Rusinek;Mony J. de Leon;Lidia Glodzik;S. de Santi;P. Doraiswamy;J. Petrella;T. Wong;Steven E. Arnold;J. Karlawish;David A. Wolk;Charles D. Smith;G. Jicha;Peter Hardy;P. Sinha;Elizabeth Oates;G. Conrad;Oscar L. Lopez;M. Oakley;D. Simpson;A. Porsteinsson;B. Goldstein;K. Martin;K. Makino;M. Ismail;C. Brand;R. Mulnard;G. Thai;Catherine Mc Adams Ortiz;Kyle Womack;D. Mathews;M. Quiceno;R. D. Arrastia;Richard D. King;Myron Weiner;K. M. Cook;Michael D. Devous;A. Levey;J. Lah;J. Cellar;Jeffrey M. Burns;H. Anderson;R. Swerdlow;Liana G. Apostolova;K. Tingus;Ellen Woo;Daniel H. S. Silverman;Po H. Lu;G. Bartzokis;Neill R. Graff Radford;F. Parfitt;Tracy Kendall;Heather K. Johnson;Marty Farlow;A. Hake;Brandy R. Matthews;S. Herring;Cynthia Hunt;Christopher H. van Dyck;Richard E. Carson;M. Macavoy;H. Chertkow;Howard Bergman;C. Hosein;S. Black;B. Stefanovic;Curtis Caldwell;G. R. Hsiung;H. Feldman;B. Mudge;M. Assaly;Andrew Kertesz;J. Rogers;D. Trost;C. Bernick;D. Munic;D. Kerwin;M.;K. Lipowski;Chuang‐Kuo Wu;N. Johnson;C. Sadowsky;Walter Martínez;Teresa Villena;R. S. Turner;K. Johnson;B. Reynolds;R. Sperling;Keith A. Johnson;G. Marshall;Meghan T. Frey;Jerome A. Yesavage;Joy Taylor;B. Lane;A. Rosen;Jared S. Tinklenberg;M. Sabbagh;C. Belden;S. Jacobson;Sherye A. Sirrel;Neil W. Kowall;Ronald J Killiany;A. Budson;A. Norbash;P. L. Johnson;T. Obisesan;S. Wolday;Joanne S. Allard;Alan J Lerner;P. Ogrocki;Leon Hudson;E. Fletcher;O. Carmichael;J. Olichney;Charlie S. DeCarli;S. Kittur;Michael Borrie;T. Lee;Rob Bartha;S. Johnson;Sanjay Asthana;C. Carlsson;S. Potkin;Adrian Preda;D. Nguyen;P. Tariot;A. Fleisher;Stephanie A. Reeder;V. Bates;H. Capote;M. Rainka;D. Scharre;M. Kataki;Anahita Adeli;E. Zimmerman;D. Celmins;Alice D. Brown;G. D. Pearlson;K. Blank;K. Anderson;R. Santulli;T. Kitzmiller;Eben S. Schwartz;K. Sink;J. Williamson;P. Garg;F. Watkins;Brian R. Ott;H. Querfurth;G. Tremont;S. Salloway;P. Malloy;Stephen Correia;H. Rosen;Bruce L. Miller;Jacobo Mintzer;K. Spicer;David Bachman;E. Finger;S. Pasternak;I. Rachinsky;J. Rogers;Andrew Kertesz;D. Drost;N. Pomara;R. Hernando;A. Sarrael;Susan K. Schultz;L. Ponto;H. Shim;K. Smith;N. Relkin;G. Chaing;Lisa Raudin;Amanda G. Smith;K. Fargher;B. A. Raj
  • 通讯作者:
    B. A. Raj
Case 7-1988
案例7-1988
  • DOI:
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Neil W. Kowall;R. A. Sobel
  • 通讯作者:
    R. A. Sobel
Elevation of endoplasmic reticulum (ER) stress-mediated Ca<sup>2+</sup> release leads to tauopathy in chronic traumatic encephalopathy (CTE)
  • DOI:
    10.1016/j.ibror.2019.07.295
  • 发表时间:
    2019-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hyeonjoo Im;Yunha Kim;Sung Soo Im;Yun Kyung Kim;Seung Jae Hyeon;Junghee Lee;Neil W. Kowall;Sooyoung Chung;Ann C. Mckee;Hoon Ryu
  • 通讯作者:
    Hoon Ryu
Impaired EWSR1 activity leads to oligodendrocyte dysfunction and demyelination of motor neurons in amyotrophic lateral sclerosis (ALS)
  • DOI:
    10.1016/j.ibror.2019.07.371
  • 发表时间:
    2019-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mi-Hyun Choi;Phuong T. Nguyen;Eunmi Kim;Hyun Soo Shim;Seung Jae Hyeon;Yun Ha Kim;Yu Jin Hwang;Neil W. Kowall;Sean Bong Lee;Junghee Lee;Hae-Chul Park;Hoon Ryu
  • 通讯作者:
    Hoon Ryu

Neil W. Kowall的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Neil W. Kowall', 18)}}的其他基金

Boston University Alzheimer's Disease Research Center
波士顿大学阿尔茨海默病研究中心
  • 批准号:
    10264287
  • 财政年份:
    2021
  • 资助金额:
    $ 39.97万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10468306
  • 财政年份:
    2021
  • 资助金额:
    $ 39.97万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10264288
  • 财政年份:
    2021
  • 资助金额:
    $ 39.97万
  • 项目类别:
VA Biorepository Brain Bank
VA 生物储存库脑库
  • 批准号:
    8661513
  • 财政年份:
    2014
  • 资助金额:
    $ 39.97万
  • 项目类别:
VA Biorepository: Gulf War Veterans' Illnesses Biorepository
VA 生物储存库:海湾战争退伍军人疾病生物储存库
  • 批准号:
    9402030
  • 财政年份:
    2014
  • 资助金额:
    $ 39.97万
  • 项目类别:
Epigenetic mechanisms relevant to the pathogenesis of ALS
ALS发病机制相关的表观遗传机制
  • 批准号:
    8597391
  • 财政年份:
    2011
  • 资助金额:
    $ 39.97万
  • 项目类别:
Alzheimer's disease translational research training
阿尔茨海默病转化研究培训
  • 批准号:
    8446333
  • 财政年份:
    2011
  • 资助金额:
    $ 39.97万
  • 项目类别:
Epigenetic mechanisms relevant to the pathogenesis of ALS
ALS发病机制相关的表观遗传机制
  • 批准号:
    8043487
  • 财政年份:
    2011
  • 资助金额:
    $ 39.97万
  • 项目类别:
Epigenetic mechanisms relevant to the pathogenesis of ALS
ALS发病机制相关的表观遗传机制
  • 批准号:
    8245574
  • 财政年份:
    2011
  • 资助金额:
    $ 39.97万
  • 项目类别:
Alzheimer's disease translational research training
阿尔茨海默病转化研究培训
  • 批准号:
    8660258
  • 财政年份:
    2011
  • 资助金额:
    $ 39.97万
  • 项目类别:

相似国自然基金

问责制度何以影响地方政府绩效——目标责任制情境下的“问责悖论”研究
  • 批准号:
    71103140
  • 批准年份:
    2011
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Tipuna Project: Intergenerational Healing, Settler Accountability and Decolonising Participatory Action Research in Aotearoa
Tipuna 项目:新西兰的代际疗愈、定居者责任和非殖民化参与行动研究
  • 批准号:
    AH/X008223/1
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
    Research Grant
Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)
阿尔茨海默病和相关痴呆症(ADRD)便携式心理物理和生理测试纲要的开发和评估
  • 批准号:
    10699349
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS
BPCA 儿科治疗的创新试验设计和检测开发
  • 批准号:
    10936040
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10613999
  • 财政年份:
    2020
  • 资助金额:
    $ 39.97万
  • 项目类别:
Precision Medicine in the Diagnosis of Genetic Disorders in Neonates
精准医学在新生儿遗传性疾病诊断中的应用
  • 批准号:
    10460478
  • 财政年份:
    2018
  • 资助金额:
    $ 39.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了